|
May 07, 2012, 03.11 PM IST
Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said.
One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage. Elder Pharma Joint Managing Director Alok Saxena denied that the company was looking to sell the business. "We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters. The nutrition supplements market in India, home to more than 1.3 billion people, is relatively undeveloped and valued at about USD 1 billion, according to the lobby group Federation of Indian Chambers of Commerce and Industry. A rapidly expanding middle-class, increasing incidence of diabetes and longer life spans are driving demand for nutrition products in India, an opportunity that has caught the attention of multinationals.
Last year, French drugmaker Sanofi's Set email alert for Tags: Elder Pharmaceuticals, Alok Saxena
|
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
